Compare BJ & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJ | PEN |
|---|---|---|
| Founded | 1984 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 14.0B |
| IPO Year | 2018 | 2015 |
| Metric | BJ | PEN |
|---|---|---|
| Price | $96.70 | $338.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 17 |
| Target Price | $109.40 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 1.7M | 665.3K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.09 | ★ 1155.56 |
| EPS | 3.42 | ★ 4.52 |
| Revenue | ★ $20,501,804,000.00 | $1,403,665,000.00 |
| Revenue This Year | $9.10 | $14.20 |
| Revenue Next Year | $6.71 | $13.60 |
| P/E Ratio | ★ $28.83 | $75.34 |
| Revenue Growth | 2.67 | ★ 17.50 |
| 52 Week Low | $86.68 | $221.26 |
| 52 Week High | $121.10 | $362.41 |
| Indicator | BJ | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 47.41 |
| Support Level | $95.12 | $338.08 |
| Resistance Level | $99.52 | $344.07 |
| Average True Range (ATR) | 3.47 | 2.27 |
| MACD | -0.32 | -0.77 |
| Stochastic Oscillator | 36.11 | 11.61 |
BJ's Wholesale Club, founded in 1984, operates a membership-based warehouse club model primarily along the US East Coast, with roughly 250 clubs and a growing domestic presence across 21 states. In fiscal 2024, the company generated over $20 billion in revenue. BJ's offers a value-oriented assortment skewed toward grocery, perishables, and consumables (71% of sales), general merchandise (11%), and gasoline (18%). Its business model is supported by recurring membership fee income and private-label brands such as Wellsley Farms and Berkley Jensen.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.